| Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer S Stolzenburg, AS Beltran, T Swift-Scanlan, AG Rivenbark, R Rashwan, ... Oncogene 34 (43), 5427-5435, 2015 | 101 | 2015 |
| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... Oncotarget 7 (37), 60535, 2016 | 82 | 2016 |
| Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide A Sorolla, D Ho, E Wang, CW Evans, CFG Ormonde, R Rashwan, ... Nanoscale 8 (17), 9343-9353, 2016 | 27 | 2016 |
| The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer E Golden, R Rashwan, EA Woodward, A Sgro, E Wang, A Sorolla, ... Nature Communications 12 (1), 1920, 2021 | 23 | 2021 |
| Molecular, Cellular and Functional Changes in the Retinas of Young Adult Mice Lacking the Voltage-Gated K+ Channel Subunits Kv8.2 and K2.1 X Jiang, R Rashwan, V Voigt, J Nerbonne, DM Hunt, LS Carvalho International journal of molecular sciences 22 (9), 4877, 2021 | 10 | 2021 |
| Validating fluorescent Chrnb4. EGFP mouse models for the study of cone photoreceptor degeneration AA Brunet, PI Fuller-Carter, AL Miller, V Voigt, S Vasiliou, R Rashwan, ... Translational Vision Science & Technology 9 (9), 28-28, 2020 | 8 | 2020 |
| The role of voltage-gated ion channels in visual function and disease in mammalian photoreceptors R Rashwan, DM Hunt, LS Carvalho Pflügers Archiv-European Journal of Physiology 473 (9), 1455-1468, 2021 | 7 | 2021 |
| Streptococcus pneumoniae potently induces cell death in mesothelial cells R Rashwan, JF Varano della Vergiliana, SM Lansley, HM Cheah, ... Plos one 13 (7), e0201530, 2018 | 6 | 2018 |
| Increased H3K27 trimethylation contributes to cone survival in a mouse model of cone dystrophy AL Miller, PI Fuller-Carter, K Masarini, M Samardzija, KW Carter, ... Cellular and Molecular Life Sciences 79 (8), 409, 2022 | 3 | 2022 |
| KCNV2 Variants and Their Use S Sultanov, M Sultanova, L Carvalho, D Hunt, R Rashwan, PY Volchkov US Patent App. 17/748,611, 2022 | 1 | 2022 |
| Multifunctional polymer nanoparticles: Combinatorial therapy for triple negative breast cancers C Evans, A Sorolla, D Ho, E Wang, C Ormonde, R Rashwan, S Iyer, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | 1 | 2016 |
| Staphylococcus aureus, but not other bacterial empyema pathogens, induce the release of selected cytokines from mesothelial cells Y Lee, J Varnao, R Rashwan, G Waterer, T Townsend, I Kay Respirology 19, 128-128, 2014 | 1 | 2014 |
| AAV capsid bioengineering in primary human retina models A Westhaus, SS Eamegdool, M Fernando, P Fuller-Carter, AA Brunet, ... Scientific Reports 13 (1), 21946, 2023 | | 2023 |
| AAV capsid bioengineering in primary human retina A Westhaus, SS Eamegdool, M Fernando, P Fuller-Carter, AA Brunet, ... | | 2023 |
| Pre-clinical efficacy testing of AAV-based gene therapy for KCNV2-deficiency. L Carvalho, R Rashwan, XR Lim, A Brunet, AL Miller, Y Bhatt, ... Investigative Ophthalmology & Visual Science 64 (8), 477-477, 2023 | | 2023 |
| Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer A Redfern, R Rashwan, A Sorolla, M Ratajska, I Kardas, A Kuzniacka, ... Cancer Research 76, 2016 | | 2016 |
| Abstract P2-06-01: Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer A Redfern, R Rashwan, A Sorolla, M Ratajska, I Kardas, A Kuzniacka, ... Cancer Research 76 (4_Supplement), P2-06-01-P2-06-01, 2016 | | 2016 |
| Molecular characterisation of C11orf67 in luminal breast cancer RMKMM Rashwan | | 2016 |
